JP2023546277A5 - - Google Patents
Info
- Publication number
- JP2023546277A5 JP2023546277A5 JP2023547735A JP2023547735A JP2023546277A5 JP 2023546277 A5 JP2023546277 A5 JP 2023546277A5 JP 2023547735 A JP2023547735 A JP 2023547735A JP 2023547735 A JP2023547735 A JP 2023547735A JP 2023546277 A5 JP2023546277 A5 JP 2023546277A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- fragment
- cells
- cancer
- immunoactive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020120869 | 2020-10-14 | ||
| CNPCT/CN2020/120869 | 2020-10-14 | ||
| CN2020122188 | 2020-10-20 | ||
| CNPCT/CN2020/122188 | 2020-10-20 | ||
| PCT/CN2021/123892 WO2022078465A1 (en) | 2020-10-14 | 2021-10-14 | Novel anti-cd47 antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023546277A JP2023546277A (ja) | 2023-11-01 |
| JP2023546277A5 true JP2023546277A5 (cg-RX-API-DMAC7.html) | 2024-12-11 |
Family
ID=81207683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023547735A Withdrawn JP2023546277A (ja) | 2020-10-14 | 2021-10-14 | 新規の抗ｃｄ４７抗体及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230399400A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4229088A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023546277A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230114745A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116348601A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021360633A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3198895A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2023005611A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL302112A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023004223A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202229351A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022078465A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017332960B2 (en) | 2016-10-20 | 2019-09-12 | I-Mab Biopharma Us Limited | Novel CD47 monoclonal antibodies and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017332960B2 (en) * | 2016-10-20 | 2019-09-12 | I-Mab Biopharma Us Limited | Novel CD47 monoclonal antibodies and uses thereof |
| WO2019091473A1 (en) * | 2017-11-10 | 2019-05-16 | I-Mab Biopharma Co., Ltd. | Fusion proteins containing cd47 antibodies and cytokines |
| WO2020036977A1 (en) * | 2018-08-13 | 2020-02-20 | Arch Oncology, Inc. | Therapeutic cd47 antibodies |
| AU2019370754A1 (en) * | 2018-10-31 | 2021-02-04 | I-Mab Biopharma Us Limited | Novel CD47 antibodies and methods of using same |
| CA3097443A1 (en) * | 2018-11-12 | 2020-05-22 | I-Mab Biopharma Us Limited | Fusion proteins containing cd47 antibodies and cytokines |
-
2021
- 2021-10-14 AU AU2021360633A patent/AU2021360633A1/en not_active Abandoned
- 2021-10-14 KR KR1020237016071A patent/KR20230114745A/ko not_active Withdrawn
- 2021-10-14 EP EP21879507.8A patent/EP4229088A1/en not_active Withdrawn
- 2021-10-14 US US18/249,054 patent/US20230399400A1/en active Pending
- 2021-10-14 MX MX2023004223A patent/MX2023004223A/es unknown
- 2021-10-14 JP JP2023547735A patent/JP2023546277A/ja not_active Withdrawn
- 2021-10-14 TW TW110138242A patent/TW202229351A/zh unknown
- 2021-10-14 WO PCT/CN2021/123892 patent/WO2022078465A1/en not_active Ceased
- 2021-10-14 CA CA3198895A patent/CA3198895A1/en active Pending
- 2021-10-14 IL IL302112A patent/IL302112A/en unknown
- 2021-10-14 CN CN202180068919.2A patent/CN116348601A/zh active Pending
-
2023
- 2023-05-02 CO CONC2023/0005611A patent/CO2023005611A2/es unknown